Preview

Journal of Anatomy and Histopathology

Advanced search

Survival Rates and Clinical Effectiveness of Vitrified Human Blastocysts in the Practice of Embryological Laboratories

https://doi.org/10.18499/2225-7357-2020-9-2-35-39

Abstract

Objectiveto carry out comparative analysis of embryo survival and pregnancy rate after the vitrification of human embryos at different stages of the preimplantation development.

Material and methods. A total of 1311 embryos were analyzed. For vitrification of embryos, the Irvine Scientific media (USA) and the CryoTop open-type carriers (Japan) were used. The vitrification and the defrosting of embryos were carried out according to the manufacturer's recommendations. The statistical processing of the results was performed on a computer in the statistical computing environment R (R V. 3. 5. 3, RStudio V. 1. 1. 463), the primary data entry was performed using MS Excel spreadsheets. We used methods of descriptive statistics, tests for comparing proportions, including an accurate binomial test for small samples and a single-sample test of proportions with continuity correction for large samples.

Results. The range of the embryo survival is quite wide and ranges from 75% to 100%. When conducting a detailed analysis of the dependence of the pregnancy rate on the stage of cryopreserved blastocysts, we found a direct link between the clinical indicators and the structure of the embryos of 5–6 days of the preimplantation development. The blastocysts with the highest degree of the internal cell mass and the trophoblast formation in combination with a high degree of the expansion (4) give the best results of the clinical pregnancy rate.

Conclusions. When performing vitrification we found out that the stage of the blastocyst development influences their survival and pregnancy rates. The phenomenon of hatching in the embryos of 5–6-day preimplantation development should be regarded as a factor that reduces the success of vitrification.

About the Authors

O. V. Ivanova
Samara State Medical University
Russian Federation
ul. Chapaevskaya, 89, Samara, 443099, Russian Federation



O. V. Shurygina
Samara State Medical University, Medical company IDK
Russian Federation
Samara


A. A. Petrova
Medical company IDK
Russian Federation
Samara


S. N. Yukhimets
Medical University Reaviz
Russian Federation
Samara


O. V. Kulakova
Samara State Medical University
Russian Federation
Samara


D. Y. Rusakov
Samara State Medical University, Medical company IDK
Russian Federation
Samara


N. N. Demidova
Medical company IDK
Russian Federation
Samara


References

1. Ivanova OV, Shurygina OV, Rusakov DYu, Bykova TV, et al. The evaluation of the efficiency of the cryopreservation of human's gametes and embryos in assisted reproductive technology program. Morphological Newsletter. 2019;7(3):46–50 (in Russian).

2. Krasnopolskaya KV, Beketova AN, Sesina NI, Chinchenko NK, Koneeva TO, Bocharova TV. A comparison of the effectiveness of fresh or frozen embryo transfer on day 5 or day 6. Problemy reproduktsii. 2019;25(5):86–91 (in Russian). doi: 10.17116/repro20192505186

3. Kravchuk YN, Kalugina AS, Bystrova OV, Shlykova SA. Effectiveness and outcomes of embryo cryopreservation programs in assisted reproductive technologies. Journal of Obstetrics and Women's Diseases. 2014;63(4):39–46 (in Russian).

4. Protopopova NV, Druzhinina EB, Mylnikova UV, Boldonova NA, Dvoryanov JA, Krylova KV, et al. Efficiency of cryoperenosis depending on various factors. Gynecology. 2018;20(5):59–62 (in Russian). doi: 10.26442/2079-5696_2018.5.59-62

5. Shurygina OV, Tugushev MT, Bayzarova AA, Saraeva NV. The vitrification of gametes and embryos is an effectiv instrument of increasing the results of the assisted reproductive technologies (ART) programs. Modern problems of science and education. 2016;4:54 (in Russian).

6. Kirienko KV, Apryshko VP, Yakovenko SA. Assisted hatching (literature review). Problemy reproduktsii. 2019;25(4):89–101 (in Russian). doi: 10.17116/repro20192504189

7. Arav A. Cryopreservation of oocytes and embryos. Theriogenology. 2014 Jan;81(1):96–102. doi: 10.1016/j.theriogenology.2013.09.011

8. Gardner DK, Schoolcraft WB. In vitro culture of human blastocysts. Towards reproductive certainty?: fertility and genetics beyond 1999?: the plenary proceedings of the 11th World Congress in In Vitro Fertilization & Human Reproductive Genetics. New York: Parthenon Pub. Group; 1999.

9. Kuwayama M. Highly efficient vitrification for cryopreservation of human oocytes and embryos: The Cryotop method. Theriogenology. 2007 Jan;67(1):73–80. doi: 10.1016/j.theriogenology.2006.09.014

10. Racowsky C, Vernon M, Mayer J, Ball GD, Behr B, Pomeroy KO, et al. Standardization of grading embryo morphology. Journal of Assisted Reproduction and Genetics. 2010 Jun 9;27(8):437–9. doi: 10.1007/s10815-010-9443-2

11. Sciorio R, Thong KJ, Pickering SJ. Single blastocyst transfer (SET) and pregnancy outcome of day 5 and day 6 human blastocysts vitrified using a closed device. Cryobiology. 2018 Oct;84:40–5. doi: 10.1016/j.cryobiol.2018.08.004

12. Seshagiri PB, Sen Roy S, Sireesha G, Rao RP. Cellular and molecular regulation of mammalian blastocyst hatching. Journal of Reproductive Immunology. 2009 Dec;83(1–2):79–84. doi: 10.1016/j.jri.2009.06.264

13. Thurin A, Hardarson T, Hausken J, Jablonowska B, Lundin K, Pinborg A, et al. Predictors of ongoing implantation in IVF in a good prognosis group of patients. Human Reproduction. 2005 Mar 17;20(7):1876–80. doi: 10.1093/humrep/deh872


Review

For citations:


Ivanova O.V., Shurygina O.V., Petrova A.A., Yukhimets S.N., Kulakova O.V., Rusakov D.Y., Demidova N.N. Survival Rates and Clinical Effectiveness of Vitrified Human Blastocysts in the Practice of Embryological Laboratories. Journal of Anatomy and Histopathology. 2020;9(2):35-39. (In Russ.) https://doi.org/10.18499/2225-7357-2020-9-2-35-39

Views: 485


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2225-7357 (Print)